Unfortunately, existing antiepileptic treatments are far from meeting the clinical needs of epilepsy patients, and about 30% of epilepsy patients are suffering from refractory epilepsy which cannot be ...
Of more than 1.4 million active patients, almost one third have 5 or more years of follow-up data in the database, including information on demographics, therapy, dosage, indication, prescription ...